Olimel Perifer N4e

Valine, Alanine, Arginine, Histidine, Isoleucine, Leucine, Methionine, Phenylalanine, Proline, Serin, the active ingredient in Olimel Perifer N4e, is a mixture of essential and non‑essential amino acids presented as a sterile powder for intravenous use. It supports metabolic processes and protein synthesis in patients requiring nutritional supplementation.

GNH USA supplies Olimel Perifer N4e as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals and transplant centres worldwide.

Olimel Perifer N4e provides amino acid supplementation for conditions that increase protein catabolism. It is used in clinical settings to support: - Post‑operative recovery: helps maintain nitrogen balance during the healing phase. - Severe trauma or burns: supplies essential amino acids to support tissue repair. - Long‑term parenteral nutrition: provides a balanced amino acid profile for patients unable to receive enteral feeding.

Amino acid solutions are generally well tolerated, but adverse reactions can occur.

Common Side Effects: - Mild nausea or vomiting: transient gastrointestinal discomfort. - Transient hyperglycaemia: elevation of blood glucose that resolves with monitoring. - Local irritation at the infusion site: redness or mild pain. - Headache: mild, self‑limiting. - Electrolyte shifts: mild changes in serum potassium or calcium. - Fever: low‑grade temperature rise during infusion.

Serious or Rare Side Effects: - Anaphylactic reaction: sudden onset of urticaria, bronchospasm, or hypotension. - Severe hyperosmolarity: rapid infusion may cause osmotic imbalance. - Metabolic acidosis: rare but possible with prolonged high‑dose use. - Thrombophlebitis: inflammation of the vein with clot formation. - Renal dysfunction: acute changes in kidney function in susceptible patients. - Sepsis: contamination‑related infection, though extremely rare with aseptic preparation.

When prescribing Olimel Perifer N4e, clinicians should consider patient‑specific factors and monitor relevant parameters.

- Assess renal function: adjust infusion rate in patients with impaired clearance. - Monitor blood glucose: amino acids can affect glycaemic control, especially in diabetics. - Check electrolyte balance: watch for shifts in potassium, calcium, and phosphate. - Observe for infusion reactions: be prepared to manage hypersensitivity. - Use aseptic technique: maintain sterility throughout preparation and administration. - Store at ambient temperature: keep in the original packaging, protect from moisture and direct sunlight.

Amino acid solutions may interact with certain medications or clinical conditions.

Major Interactions (Avoid): - High‑dose insulin therapy: may exacerbate hypoglycaemia when combined with amino acid‑induced glucose shifts. - Potassium‑sparing diuretics: increase risk of hyperkalaemia when large amino acid loads are infused.

Moderate Interactions (Monitor Closely): - Anticoagulants (e.g., heparin): monitor coagulation parameters as amino acids can affect plasma protein binding. - Corticosteroids: may increase protein catabolism, requiring adjustment of amino acid dosing. - Loop diuretics: monitor electrolytes closely due to combined effects on renal excretion. - Beta‑blockers: may mask tachycardia that can signal infusion reactions. - Parenteral lipid emulsions: coordinate infusion timing to avoid incompatibility.